Evidence map›Paper›PMID 40392405›Full record

ArticleArchives of dermatological research2025

Correction: LncRNA H19 inhibited dermal papilla cell senescence process through miR-29a by targeting Wnt/β-catenin signaling pathway.

Zhenyu Liu, Shenyu Li, Qilin Yang, Guiyuan Cao, Wenjie Yan, Siyuan Jiang, Ruilong Qiao, Bozhi Cai, Zhihao Wu, Changmin Lin and 1 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Zhenyu LiuKey Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin, Guangxi, 541004, P. R. China.
Shenyu LiDepartment of Neurosurgery, Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, 541100, P. R. China.
Qilin YangKey Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin, Guangxi, 541004, P. R. China.
Guiyuan CaoKey Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin, Guangxi, 541004, P. R. China.
Wenjie YanDepartment of Dermatology, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, 541001, P. R. China.
Siyuan JiangKey Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin, Guangxi, 541004, P. R. China.
Ruilong QiaoKey Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin, Guangxi, 541004, P. R. China.
Bozhi CaiTissue Engineering Laboratory, First Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, 515000, P. R. China.
Zhihao WuKey Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin, Guangxi, 541004, P. R. China.
Changmin LinDepartment of Histology and Embryology, Shantou University Medical College, No. 22, Xinling Road, Shantou, Guangdong, 515041, P. R. China. cocolin@126.com.
Ningxia ZhuKey Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin, Guangxi, 541004, P. R. China. znx103@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40392405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.